8
Oct
2024

Anemocyte SRL

Exhibitor at CPHI Milan 2024 stand 3D105, BioProduction
About Us

Anemocyte is a Biotech Manufacturing Organization (BMO); a biotech company active in the field of Cell and Gene Therapies (CGTs) that addresses CGT needs pro-actively offering one stop shop solutions and fostering exciting innovations.
Our business:

- Process development and GMP capabilities (Somatic Cells, Non-Viral Modified Cells, Vesicles)
- Plasmids for Viral Vector and RNA Manufacturing
- Project Exellula: to address up to commercial scale needs for CGTs Including Viral Vectors modified cells.
- Big Data Analysis of CGTs

...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IT
  • 2018
    On CPHI since
  • 1
    Certificates
Company types
Other
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 3D105, BioProduction

Products Featured at CPHI Milan 2024

  • Cell therapy manufacturing

    Product Cell therapy manufacturing

    Development, optimization and GMP manufacturing of cell therapy products. 

    Manufacturing Highlights:

    • Manufacturing of autologous and allogeneic cell therapy products.• Non-viral gene modification.
    • Process an...
  • Plasmid DNA

    Product Plasmid DNA

    Manufacturing of plasmid DNA as starting material for:

    • Clinical manufacturing of gene and immuno-oncology therapies, for example in AAV or lentiviral vector.
    • Clinical manufacturing of biological drugs.

    Quality Highlights:
    ...